Wu Shike, Lai Hao, Zhao Jiangyang, Deng Xin, Wei Jianbao, Liang Jian, Mo Xianwei, Chen Jiansi, Lin Yuan
Department of Gastrointestinal and Anal Surgery, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning 530001, Guangxi Zhuang Autonomous Region; Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University Nanning 530021, Guangxi Autonomous Region, China.
Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University Nanning 530021, Guangxi Autonomous Region, China.
J Minim Access Surg. 2018 Jan-Mar;14(1):1-8. doi: 10.4103/0972-9941.195573.
There is no consensus that single-incision laparoscopic surgery splenectomy (SILS-SP) is on a par with conventional multiport laparoscopic surgery splenectomy (CMLS-SP).
The aim of this systematic review and meta-analysis was to assess feasibility and safety of SILS-SP when compared with CMLS-SP.
Eligible articles were identified by searching several databases including PubMed, EMBASE, CNKI (China) and the Cochrane Library, up until February 2016. Studies were reviewed independently and rated by Newcastle-Ottawa Quality Assessment Scale. Evaluated outcomes were complications, operative time, post-operative hospital stay, blood loss, starting diet, post-operative pain scores, conversion and analgesic requirements.
Ten retrospective studies met the eligibility criteria. Overall, there was no significant difference between SILS-SP and CMLS-SP in complications, operative time, post-operative hospital stay, blood loss, starting diet, post-operative pain scores, conversion and analgesic requirements.
SILS-SP is feasible and safe in certain patients, with no obvious advantages over CMLS-SP. Therefore, it may be considered an alternative to CMLS-SP. We await high-quality, double-blind RCTs. These should include clear statements on standard scores of post-operative pain and cosmetic results, longer follow-up assessment and cost-benefit analysis.
对于单孔腹腔镜脾切除术(SILS-SP)是否与传统多孔腹腔镜脾切除术(CMLS-SP)相当,目前尚无共识。
本系统评价和荟萃分析的目的是评估SILS-SP与CMLS-SP相比的可行性和安全性。
通过检索包括PubMed、EMBASE、中国知网(CNKI)和考克兰图书馆在内的多个数据库,确定截至2016年2月符合条件的文章。由独立评审员对研究进行评估,并采用纽卡斯尔-渥太华质量评估量表进行评分。评估的结果包括并发症、手术时间、术后住院时间、失血量、开始进食时间、术后疼痛评分、中转率和镇痛需求。
十项回顾性研究符合纳入标准。总体而言,SILS-SP与CMLS-SP在并发症、手术时间、术后住院时间、失血量、开始进食时间、术后疼痛评分、中转率和镇痛需求方面无显著差异。
SILS-SP在某些患者中是可行且安全的,与CMLS-SP相比无明显优势。因此,它可被视为CMLS-SP的一种替代方法。我们期待高质量的双盲随机对照试验。这些试验应包括关于术后疼痛标准评分和美容效果的明确说明、更长时间的随访评估以及成本效益分析。